Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines

Journal of Submicroscopic Cytology and Pathology

Volumn 29, Issue 1, 1997, Pages 1-17

  Mohamood, A S ^a   Gyles, P ^a   Balan, K V ^a   Hollis, V W ^a   Eckberg, W R ^a   Asseffa, A ^a   Han, Z ^b   Wyche, J H ^b   Anderson, W A ^a  

^a HOWARD UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrogen receptor; Growth factor receptor; Protooncogene protein

Indexed keywords

ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; ONCOPROTEIN; PHOSPHOTYROSINE; PROTEIN KINASE;

ARTICLE; BREAST TUMOR; CARCINOMA; CELL CULTURE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ACTINS; BREAST NEOPLASMS; CARCINOMA; ESTROGENS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHOTYROSINE; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, GROWTH FACTOR; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030642041     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ANGEL P., ALLEGRETTO E.A., OKINO S.T., HATTORI K., BOYLE W.J., HUNTER T. and KARIN M., 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature, 332, 166-171.
2. BARGMAN C.I., HUNG M.-C. and WEINBERG R.A., 1986. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226-230.
3. BENDAYAN M. and STEPHENS H., 1984. Double labelling cytochemistry applying the protein A-gold technique. In: 'Immunolabelling for Electron Microscopy'. Polak J.M. and Varndell I.M. eds., Elsevier, Amsterdam, pp. 113-121.
4. BERTHOIS Y., KATZENELLENBOGEN J.A. and KATZENELLENBOGEN B.S., 1986. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA, 83, 2496-2500.
5. BHATTACHARYYA N., RAMSAMMY R., EATMAN E., HOLLIS V.W. and ANDERSON W.A., 1994. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen. J. Submicrosc. Cytol. Pathol., 26, 147-162.
6. BOHMANN D., BOS T.J., ADMON A., NISHIMURA T., VOGT P.K. and TJIAN R., 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science, 238, 1386-1392.
7. CHIU R., BOYLE W.J., MEEK J., SMEAL T., HUNTER T. and KARIN M., 1988. The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell, 54, 541-552.
8. CHRYSOGELOS S.A. and DICKSON R.B., 1994. EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res. Treat., 29, 29-40.
9. DATI C., ANTONIOTTI S., TAVERNA D., PERROTEAU I. and DE BORTOLI M., 1990. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene, 5, 1001-1006.
10. DAVIDSON N.E., GELMANN E.P., LIPPMAN M.E. and DICKSON R.B., 1987. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1, 216-223.
11. DE BORTOLI M., DATI C., ANTONIOTTI S., MAGGIORA P. and SAPEI M.L., 1992. Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells. J. Steroid Biochem., 43, 21-25.
12. DENT P., HASER W., HAYSTEAD T.A.J., VINCENT L.A., ROBERTS T.M. and STURGILL T.W., 1992. Activation of mitogen-activated protein kinase kinase by v-raf in NIH 3T3 cells and in vitro. Science, 257, 1404-1407.
13. DIAUGUSTINE R.P., PETRUEZ P., BELL G.I., BROWN C.F., KORACH K.S., MCLACHLAN J.A. and TENG C.T., 1988. Influence of estrogen on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology, 122, 2355-2363.
14. DOWNWARD J., YARDEN Y., MAYES E., SCRACE G., TOTTY N., STOCKWELL P., ULLRICH A., SCHLESSINGER J. and WATERFIELD M.D., 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature, 307, 521-527.
15. FURLOW J.D., AHRENS H., MUELLER G.C. and GORSKI J., 1990. Anti-sera to a synthetic peptide recognize native and denatured rat estrogen receptor. Endocrinology, 127, 1028-1032.
16. GORSKI J., TOFF D., SHYMATA G., SMITH D. and NOTIDES A., 1968. Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog. Horm. Res., 29, 45.
17. HALAZONETIS T.D., GEORGOPOULOS K., GREENBERG M.E. and LEDER P., 1988. c-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities. Cell, 55, 917-924.
18. HOLT J.T., GOPAL T.V., MOULTON A.D. and NIENHUIS A.W., 1986. Inducible production of c-fos anti-sense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA, 83, 4794-4798.
19. HUET-HUDSON Y.M., CHAKRABORTHY C., DE S.K., SUZUKI Y., ANDREWS G.K. and DEY S.K., 1990. Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol. Endocrinol., 4, 510-523.
20. JENSEN E.V., SUZUKI T., KAWASHIMA T., STUMPF W.E., JUNGBLUT P.W. and DESOMBRE E.R., 1968. A two step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. USA, 59, 632-635.
21. KATZENELLENBOGEN B.S. and NORMAN M.J., 1990. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-1, serum, and estrogen. Endocrinology, 126, 891-898.
22. KING W.J. and GREENE G.L., 1984. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature, 307, 745-747.
23. LEEVERS S.J., PATERSON H.F. and MARSHALL C.J., 1994. Requirement for Ras in Rat activation is overcome by targeting Raf to the plasma membrane. Nature, 369, 411-414.
24. LINGHAM R.B., STANCEL G.M. and LOOSE-MITCHELL D.S., 1988. Estrogen induction of epidermal growth factor receptor mRNA. Mol. Endocrinol., 2, 230-235.
25. MUKKU V.R. and STANCEL G.M., 1985a. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem., 260, 9820-9824.
26. MUKKU V.R. and STANCEL G.M., 1985b. Receptor for epidermal growth factor in the rat uterus. Endocrinology, 117, 149-154.
27. MUKKU V.R., KIRKLAND J.L., HARDY M. and STANCEL G.M., 1982. Hormonal control of uterine growth: temporal relationships between estrogen administration and deoxyribonucleic acid synthesis. Endocrinology, 111, 480-487.
28. NELSON K.G., TAKASHASHI T., BOSSERT N.L., WALMER D.K. and MCLACHLAN J.A., 1991. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA, 88, 21-25.
29. PRESS M.F. and GREENE G.L., 1984. An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin. Lab. Invest., 50, 480-486.
30. PRESS M.F., HOLT J.A., HERBST A.L. and GREENE G.L, 1985a. Immunocytochemical identification of estrogen receptor in ovarian carcinomas: localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab. Invest., 50, 349-361.
31. PRESS M.F., NOUSEK-GOEBL N.A. and GREENE G.L., 1985b. Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J. Histochem. Cytochem., 33, 915-924.
32. ROTH J.J., 1984. The protein A-gold technique for antigen localisation in tissue sections by light and electron microscopy. In: 'Immunolabelling for Electron Microscopy'. Polak J.M. and Varndell I.M. eds., Elsevier, Amsterdam, pp. 113-121.
33. SAINSBURY J.R.C., FARNDON J.R., SHERBET G.V. and HARRIS A.L., 1985. EGF receptors and estrogen receptors in human breast cancer. Lancet, 1, 364-366.
34. SASSONE-CORSI P., RANSONE L.J., LAMPH W.W. and VERMA I.M., 1988. Direct interactions between fos and jun nuclear oncoproteins: Role of the leucine zipper domain. Nature, 366, 690-692.
35. SLAMON D.J., GODOLPUIN W., JONES L.A., HOLT J.A., WONG S.G., KEITH D.E., LEVIN W.J., STUART S.G., UDOVE J., ULLRICH A. and PRESS M.F., 1989. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707-712.
36. SMITH M.J. and PROCHOWNICK E.V., 1992. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood, 79, 2107-2115.
37. TOMOOKA Y., DIAUGUSTINE R.P. and MCLAUCHLAN J.A., 1986. Proliferation of mouse uterine epithelial cells in vitro. Endocrinology, 118, 1011-1018.
38. VARNDELL I.M. and POLAK J.M., 1984. Double immunostaining procedures: Techniques and applications. In: 'Immunolabelling for Electron Microscopy'. Polak J.M. and Varndell I.M. eds., Elsevier, Amsterdam, pp. 113-121.
39. WEISZ A., CICATIELLO L., PERSICOT E., SCALONA M. and BRESCIANI F., 1990. Estrogen stimulates transcription of c-jun protooncogene. Mol. Endocrinol., 4, 1041-1050.
40. WELSHONS W.V., LIEBERMAN M.E. and GORSKI J., 1984. Nuclear localization of oestrogen receptors. Nature, 307, 747-749.